GATC Biotech subsidiary LifeCodexx has launched a new version of its noninvasive fetal aneuploidy test, PraenaTest Express, that has a turnaround time of one week. The express version of the test will initially be available in Germany, and after a pilot phase will be introduced in other European countries, according to the company.
Multiplicom had launched three mutation-detection kits based on the company's proprietary MASTR technology. The three kits, which detect mutations common in gastrointestinal track, colon, lung, and skin cancers, can be used in combination with all next-gen sequencing systems.